您的位置：山东大学 -> 科技期刊社 -> 《山东大学学报（医学版）》

山东大学学报（医学版） ›› 2017, Vol. 55 ›› Issue (6): 124-128.doi: 10.6040/j.issn.1671-7554.0.2016.1270

• • 上一篇    

γ-谷氨酰转肽酶与高尿酸血症关系的队列分析

曹瑾1,季晓康2,孙秀彬1,蒋正1,薛付忠1   

  1. 山东大学公共卫生学院 1. 生物统计学系;2. 信息数据处理实验室, 山东 济南 250012
  • 收稿日期:2016-10-08 出版日期:2017-06-10 发布日期:2017-06-10
  • 通讯作者: 薛付忠. E-mail:xuefzh@sdu.edu.cn E-mail:xuefzh@sdu.edu.cn
  • 基金资助:
    山东省科技发展计划(2014GSF118119)

The relationship between γ-glutamyltransferase and hyperuricemia: a cohort study

CAO Jin1, JI Xiaokang2, SUN Xiubin1, JIANG Zheng1, XUE Fuzhong1   

  1. 1. Department of Epidemiology and Biostatistics;
    2. Information and Data Analysis Lab, School of Public Health, Shandong University, Jinan 250012, Shandong, China
  • Received:2016-10-08 Online:2017-06-10 Published:2017-06-10

PDF (PC)

193

摘要： 目的 探讨γ-谷氨酰转肽酶(GGT)与高尿酸血症(HUA)发病之间的关系。 方法 本研究选取“山东多中心健康管理纵向观察队列”中26 006名体检者作为基线进行随访,构建结局为HUA的研究队列, GGT分为4个水平(由低到高分别为Q1、Q2、Q3、Q4),采用Cox比例风险回归模型分析GGT不同水平与HUA发病之间的关系。 结果 HUA发病密度为74.7/1 000人年。仅对年龄进行调整时,GGT不同水平各组(Q2、Q3、Q4)与低水平组(Q1)的相对危险度RR分别为1.64(95%CI:1.46~1.84,P<0.001)、2.24(95%CI:2.00~2.50,P<0.001)、2.68(95%CI:2.41~2.99,P<0.001);调整年龄、体质量指数、收缩压、甘油三酯、总胆固醇、高密度脂蛋白、血肌酐后RR值分别为1.20(95%CI:1.04~1.38,P<0.001)、1.43(95%CI:1.24~1.64,P<0.001)、1.51(95%CI:1.31~1.74,P<0.001);进一步调整吸烟和饮酒因素后RR值分别为1.19(95%CI:1.04~1.37,P<0.001)、1.41(95%CI:1.23~1.62,P<0.001)、1.49(95%CI:1.29~1.72,P<0.001)。 结论 GGT是HUA 发病的独立危险因素,随着GGT水平的升高,HUA的发病风险增大。

关键词: γ-谷氨酰转肽酶, 高尿酸血症, 队列研究, Cox回归

Abstract: Objective To explore the relationship between γ-glutamyltransferase(GGT)and hyperuricemia(HUA). Methods We selected 26,006 participants from the routine health check-up system in the “large sample longitudinal health management cohort data management system” as baseline to follow up and to construct the longitude cohort. After that, we divided GGT into four levels(Q1, Q2, Q3, Q4), and adopted Cox regression model to explore the relationship between GGT and HUA. Results The incidence density of HUA was 74.4/1 000 personyears. The Cox model adjusted age showed that relative hazards(RRs)of different levels(Q2, Q3, Q4)compared with the lowest level(Q1)were 1.64(95%CI: 1.46-1.84, P<0.001), 2.24(95%CI: 2.00-2.50, P<0.001), 2.68(95%CI: 2.41-2.99, P<0.001), respectively. After the age, BMI, systolic blood pressure, triglyceride, total cholesterol, high-density lipoprotein cholesterol and serum creatinine were adjusted, the RRs were 1.20(95%CI: 1.04-1.38, P<0.001), 1.43(95%CI:1.24-1.64, P<0.001), 1.51(95%CI: 1.31-1.74, P<0.001), respectively. After further adjusting for smoking and drinking, the RRs were 1.19(95%CI: 1.04-1.37, P<0.001), 1.41(95%CI:1.23-1.62, P<0.001), 1.49(95%CI: 1.29-1.72, P<0.001), respectively. Conclusion GGT is an independent risk factor of HUA. With the enhanced GGT level, the risk of developing HUA will increase.

Key words: Hyperuricemia, γ-glutamyltransferase, Cohort study, Cox model

中图分类号: 

  • R589
[1] Lim J, Yang J, Chun B, et al. Is serumγ-glutamyltransferase inversely associated with serum antioxidants as a marker of oxidative stress? [J]. Free Radical Biolo Med, 2004, 37(7):1018-1023.
[2] Hopps E, Noto D, Caimi G, et al. A novel component of the metabolic syndrome: the oxidative stress[J]. Nutr Metab Cardiovasc Dis, 2010, 20(1):72-77.
[3] Koenig G, Seneff S. Gamma-glutamyltransferase: a predictive biomarker of cellular antioxidant inadequacy and disease risk[J]. Dis Markers, 2015, 2015:818570. doi:10.1155/2015/818570.
[4] Yousefzadeh G, Shokoohi M, Yeganeh M, et al. Role of gamma-glutamyl transferase(GGT)in diagnosis of impaired glucose tolerance and metabolic syndrome: a prospective cohort research from the kerman coronary artery disease risk study(KERCADRS)[J]. Diabetes Metab Syndr, 2012, 6(4):190-194.
[5] Lee S, Kim DH, Nam HY, et al. Serum gamma-glutamyltransferase levels are associated with concomitant cardiovascular risk factors in korean hypertensive patients: a nationwide population-based study[J]. Medicine(Baltimore), 2015, 94(50): e2171. doi:10.1097/MD.0000000000002171.
[6] 邵继红, 沈霞, 李东野, 等. 高尿酸血症与代谢综合征组分关系的研究[J]. 中华流行病学杂志, 2007, 28(2):180-183. SHAO Jihong, SHEN Xia, LI Dongye, et al. Study on the relationship between composition of hyperuricemia and metabolic sydrom[J]. Chin J Epidemiol, 2007, 28(2):180-183.
[7] 顾静莉, 曹勤, 黄融, 等. 男性代谢综合征人群血清 γ-谷氨酰转肽酶水平与高尿酸血症的相关性[J]. 上海交通大学学报(医学版), 2015, 35(8):1185-1189. GU Jingli, CAO Qin, HUANG Rong, et al. Correlation between γ-glutamyltransferase and hyperuricemia of male population with metabolic sydrome[J]. Journal of Shanghai Jiaotong University(Medical Science), 2015, 35(8):1185-1189.
[8] 中华医学会内分泌学分会. 高尿酸血症和痛风治疗中国专家共识[J]. 国际内分泌代谢杂志, 2013, 29(11):913-920.
[9] 王德光, 郝丽, 戴宏, 等. 安徽省成人慢性肾脏病流行病学调查[J]. 中华肾脏病杂志, 2012, 28(2):101-105. WANG Deguang, HAO Li, DAI Hong, et al. Epidemiology study of chronic kidney disease in adult population of Anhui province[J]. Chin J Nephrol, 2012, 28(2):101-105.
[10] 阎胜利, 赵世华, 李长贵, 等. 山东沿海居民高尿酸血症及痛风五年随访研究[J]. 中华内分泌代谢杂志, 2011, 27(7):548-552. YAN Shengli, ZHAO Shihua, LI Changgui, et al. A five year follow up study on patients with gout and hyperuricemia[J]. Chin J Endocrinol Metab, 2011, 27(7):548-552.
[11] 周弋, 齐慧, 赵根明, 等. 上海市浦东新区居民高尿酸血症与慢性肾病相关性研究[J]. 中华流行病学杂志, 2012, 33(4):351-355. ZHOU Yi, QI Hui, ZHAO Genming, et al. Relationship between hyperuricemia and chronic kidney disease in Pudong New Area of Shanghai[J]. Chin J Epidemiol, 2012, 33(4):351-355.
[12] 邹贵勉, 黄江燕, 车文体, 等. 广西城市社区居民高尿酸血症流行病学调查及其与慢性肾脏病的关系[J]. 中华内分泌代谢杂志, 2011, 27(7):561-565. ZOU Guimian, HUANG Jiangyan, CHE Wenti, et al. An epidemiology study on the prevalence of hyperuricemia and its relationship to chronic kidney disease in the urban community residents of Guangxi [J]. Chin J Endocrinol Metab, 2011, 27(7):561-565.
[13] Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008[J]. Arthritis Rheum, 2011, 63(10):3136-3141.
[14] Zhu Y, Pandya BJ, Choi HK. Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008[J].Am J Med, 2012, 125(7):679-687.
[15] Nakamura K, Sakurai M, Miura K, et al. Serum gamma-glutamyltransferase and the risk of hyperuricemia:a 6-year prospective study in Japanese men [J]. Horm Metab Res, 2012, 44(13):966-974.
[16] Nakanishi N, Suzuki K, Tatara K. Serum γ-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men [J]. Diabetes care, 2004, 27(6):1427-1432.
[17] Lee DS, Evans JC, Robins SJ, et al. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk the framingham heart study [J]. Arterioscler, Thromb, Vasc Biol, 2007, 27(1): 127-133.
[18] Lee D H, Gross M D, Jacobs Jr D R. Cardiovascular risk development in young adults study. Association of serum carotenoids and tocopherols with gamma-glutamyltransferase: the Cardiovascular Risk Development in Young Adults(CARDIA)study [J]. Clin Chem, 2004, 50(3): 582-588.
[19] Emdin M, Pompella A, Paolicchi A. Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease triggering oxidative stress within the plaque [J]. Circulation, 2005, 112(14): 2078-2080.
[20] 李敏, 郑雪娜, 蒋兴亮. 尿酸与氧化应激的关系[J]. 中华临床医学医师杂志, 2010, 4(10):133-135.
[21] Sautin YY, Johnson RJ. Uric acid: the oxidant-antioxidant paradox [J]. Nucleosides, Nucleotides, Nucleic Acids, 2008, 27(6): 608-619.
[1] 李江冰,宋心红,林海燕,张冬芝,李向一,许艺博,王丽,薛付忠. 健康管理人群缺血性异常心电图的影响因素[J]. 山东大学学报（医学版）, 2017, 55(6): 77-81.
[2] 于媛媛,王春霞,苏萍,孙苑潆,薛付忠,刘言训. 健康管理队列白内障发病风险预测模型[J]. 山东大学学报（医学版）, 2017, 55(6): 104-107.
[3] 柳晓涓,蒋正,康凤玲,周苗,林伟强,薛付忠. 中性粒细胞计数与非酒精性脂肪肝关联性的前瞻性队列研究[J]. 山东大学学报（医学版）, 2017, 55(6): 119-123.
[4] 于珍珍,陈慧,杨晓云,吕明. 高尿酸血症、幽门螺杆菌感染与代谢综合征的相关性[J]. 山东大学学报（医学版）, 2017, 55(5): 76-80.
[5] 李向一,孙秀彬,鹿玉莲,申振伟,陈亚飞,唐芳,薛付忠. 子宫肌瘤与乳腺增生关联性的队列研究[J]. 山东大学学报（医学版）, 2016, 54(9): 53-58.
[6] 申振伟,季晓康,王庆莲,李洁,薛付忠,刘静. 非酒精性脂肪肝与慢性肾脏病关系的回顾性队列研究[J]. 山东大学学报（医学版）, 2016, 54(7): 43-49.
[7] 刘言训, 刘佳, 张涛, 王璐, 薛付忠, 王萍. 基于纵向监测队列的2型糖尿病与甲状腺结节的关联性[J]. 山东大学学报（医学版）, 2015, 53(8): 83-86.
[8] 王霞，高燕燕,安毅. 别嘌呤醇对高尿酸血症患者动脉弹性短期影响的临床观察[J]. 山东大学学报(医学版), 2012, 50(2): 1-.
[9] 张兰芝,周玉秀. 唐山市社区中青年痛风及高尿酸血症的流行病学调查[J]. 山东大学学报(医学版), 2010, 48(5): 163-164.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
版权所有 © 2018 《山东大学学报(医学版)》编辑部　
地址:山东大学科技期刊社（济南市历城区山大南路27号山东大学中心校区明德楼B座721室） 电话: 0531-88366918 E-mail: xbyxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发